Replies to post #312843 on Anavex Life Sciences Corp (AVXL)

[powerwalker]

If the announcement is made first thing in the morning, I expect it to be favorable for Biogen.

I thought there was going to be a hearing/presentation on Monday, not a decision necessarily.

One of my concerns about FDA's approval of adu* is that it becomes the SOC. Then, if blarcamesine receives approval in a year, will it be the new SOC or only a drug that is better? If the latter, then other drugs that are not a efficient as blarcamesine might be approved as being better than adu* though not Anavex's drug.

IMO, it would be much, much better for Anavex that blarcamesine be the first new SOC rather than a low bar set by adu* that other drugs can hop over though mot as efficient as blarcamsine.



ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!

[powerwalker]

abe, I'll throw this out there as an early Monday morning thought in regards to your comment:

If the announcement is made first thing in the morning, I expect it to be favorable for Biogen.

June 7th is the "notify by" date, not "on" date. So, Biogen made have been told late Friday afternoon and has been working on its PR over the weekend for today's release.



ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!